BEDMINSTER, N.J. and DUBLIN, Ireland, Oct. 31, 2011 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today announced that Joseph Zakrzewski, Amarin’s Chairman and CEO, has been invited to ring the closing bell at the NASDAQ MarketSite on Wednesday, Nov. 2nd at 4:00 PM ET. Mr. Zakrzewski will be joined by Amarin’s senior management team.
